A detailed history of Lgt Financial Advisors LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Lgt Financial Advisors LLC holds 119 shares of CRL stock, worth $22,312. This represents 0.06% of its overall portfolio holdings.

Number of Shares
119
Previous 205 41.95%
Holding current value
$22,312
Previous $42.3 Million 44.65%
% of portfolio
0.06%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$187.96 - $245.29 $16,164 - $21,094
-86 Reduced 41.95%
119 $23.4 Million
Q2 2024

Aug 05, 2024

SELL
$206.39 - $268.73 $58,614 - $76,319
-284 Reduced 58.08%
205 $42.3 Million
Q1 2024

May 02, 2024

SELL
$203.52 - $273.43 $4,273 - $5,742
-21 Reduced 4.12%
489 $132 Million
Q4 2023

Feb 12, 2024

SELL
$164.52 - $238.84 $2,467 - $3,582
-15 Reduced 2.86%
510 $121 Million
Q3 2023

Nov 01, 2023

BUY
$194.44 - $217.61 $102,081 - $114,245
525 New
525 $103 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.54B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Lgt Financial Advisors LLC Portfolio

Follow Lgt Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lgt Financial Advisors LLC with notifications on news.